Imolife Pharmaceuticals Private Limited
About Imolife Pharmaceuticals Private Limited
Data last updated:
Imolife Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2017PTC089460. Its GSTIN is 09AAECI4089A1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anjani Saxena and Subodh Chandra Saxena.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 08 State Bank Colony Surkha, Bareilly, Uttar Pradesh, India – 243005.
As per the financials filed for FY 2022, the company reported a revenue of ₹17.13 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹1,836 (net margin 0.1%) and EBITDA of ₹25,677 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Imolife Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address08 State Bank Colony Surkha, Bareilly, Uttar Pradesh, India – 243005
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Imolife Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Imolife Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Imolife Pharmaceuticals Private Limited, buy the company report.
Financials of Imolife Pharmaceuticals Private Limited
FY 2022 filings availableImolife Pharmaceuticals Private Limited reported revenue of ₹17.13 Lakh (up 47% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over three years, including 47% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,677 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,836 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Imolife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Imolife Pharmaceuticals Private Limited
Imolife Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjani Saxena | Director | 25 Jan 2017 | 9 Years 9 Months | Current |
| Subodh Chandra Saxena | Director | 25 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Imolife Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunsence Pharmaceuticals Private Limited | ₹17.15 Lakh (FY 2025) | 2.0% | Patna, Bihar, India | |||
| Velesta Pharmaceuticals Private Limited | ₹17.15 Lakh (FY 2024) | -41.0% | Kalyan, Maharashtra, India | |||
| Medon Pharmaceuticals Private Limited | ₹17.15 Lakh (FY 2025) | -58.0% | Ranchi, Jharkhand, India | |||
| Imolife Pharmaceuticals Private Limitedthis company | ₹17.13 Lakh (FY 2022) | ₹1,836 | 0.1% | 47.0% | Bareilly, Uttar Pradesh, India | |
| Eyeandeye Pharmaceuticals Private Limited | ₹17.09 Lakh (FY 2024) | 114.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Imolife Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Imolife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Imolife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Imolife Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECI4089A1ZN | Uttar Pradesh | Active | 19 Sep 2017 |
To see the full GST registrations and return filing status of Imolife Pharmaceuticals Private Limited, buy the company report.
Recent activity
Imolife Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anjani Saxena was appointed as Director on 25 Jan 2017.
Frequently asked questions
Imolife Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 January 2017 (9+ years old) and is registered under CIN U24290UP2017PTC089460.
Imolife Pharmaceuticals has 2 current directors:
- Anjani Saxena - Director
- Subodh Chandra Saxena - Director
The latest financial statements of Imolife Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Imolife Pharmaceuticals is 09AAECI4089A1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Imolife Pharmaceuticals is U24290UP2017PTC089460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imolife Pharmaceuticals was incorporated on 25 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Imolife Pharmaceuticals by revenue are Sunsence Pharmaceuticals Private Limited, Velesta Pharmaceuticals Private Limited, Medon Pharmaceuticals Private Limited, Eyeandeye Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anjani Saxena was appointed as Director on 25 Jan 2017. Subodh Chandra Saxena was appointed as Director on 25 Jan 2017.
The registered office of Imolife Pharmaceuticals is at 08 State Bank Colony Surkha, Bareilly, Uttar Pradesh, India – 243005.
Imolife Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Imolife Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.